Abstract:OBJECTIVE:To investigate the clinical features, critical laboratory parameters, and fetal monitoring methods in intrahepatic cholestasis of pregnancy (ICP). METHODS:A retrospective analysis of 21 cases of ICP suffered with fetal death in Women's hospital, School of Medicine, Zhejiang University from January 1999 to December 2010 were discussed. RESULTS:(1) The average age of ICP patients suffered with fetal death were (30.2 ± 4.6) years old. Among them, 4 cases were older than 35 years, six cases were multipara, one of them suffered stillbirth 2 year before. Twenty cases were singleton pregnancies and 1 case was twin pregnancy. (2) All 21 cases of fetal death occurred in the third trimester, 12 cases occurred before 37 weeks, 9 cases after 37 weeks.Nine cases were diagnosed by ultrasound in outpatient clinics, fetal heart beat disappeared in 9 patients after admission because of ICP, two disappeared after labor, one during anesthesia before emergent surgery. Perinatal mortality rate of ICP was 0.148% (21/14 184), and fetal death occurred from 29 to 41 weeks with an average gestational age of (33.8 ± 4.2) weeks. (3) Puritus occurred in all 21 cases while 11 of them had pruritus all over the body. Ten pregnant women felt the fetal movement decreased or disappeared before diagnosis of fetal death. The glycocholic acid levels increased in all of the 21 cases. Among them, glycocholic acid levels in 11 cases were (21.49 - 64.48) µmol/L, while in 10 cases were ≥ 64.48 µmol/L. Serum bile acid levels elevated in 16 cases which had been analyzed (the other 5 cases had not been checked), and the highest level reached 270 µmol/L. Serum alanine aminotransferase and aspartate aminotransferase were increased in 14 cases. Seven cases had their total bilirubin > 21 µmol/L, and 12 cases had their direct bilirubin levels significantly elevated. Among the 21 cases of ICP, 15 cases were in severe status, while the other 6 cases were mild. (4) Nine patients had no antepartum surveillance since fetal death were diagnosed before admission. The results of antepartum surveillance were as follows: 2 cases had nonreassuring nonstress test (NST), one had mild "V" type deceleration. Absence of diastolic flow in umbilical artery were found in 3 cases, and low fetal biophysical score was got in one case. (5) All 21 patients had vaginal delivery. Six of them delivered after natural contraction, and the remaining 14 cases delivered after oral intake of mifepristone and amniotic injection of ethacridine, or oxytocin induced labor within 48 hours, only one case delivered after additional dinoprostone suppositories. The appearance of fetus, placentas and membranes were normal, the lengths of umbilical cord were average. Four cases were found with cords binding the necks or the bodies. Eighteen cases had grade III amniotic fluid with meconium-stained, and 2 cases complicated by oligohydramnios. Ten cases had their fetuses and placentas examined by pathologist. Among them, one case had multiple malformations, no more obvious pathological abnormalities were found in other fetuses. Pathologic examination showed that fibrin deposited around chorion and deciduas basalis, large vessels accompanied by calcification, degeneration, hemorrhagic infarction, and increased focal syncytial nodules could be seen in all of the ten placentas. CONCLUSIONS:Fetal death in pregnant women with ICP often occurs after the contractions, Severe ICP may be a key factor that involved in the occurrence of fetal death. Up to now, there is no valid indicators in fetal monitoring, which can predict fetal death. Extensive assessment of the severity and careful antepartum surveillance should be achieved before timely termination of pregnancy.

Analysis on the efficacy of the combination of TCM and Western Medicine in treating intrahepatic cholestasis of pregnancy with different degree

A Clinical Analysis of the Rapeutic Effect for 126 Cases of ICP

[Effect of Integrative Chinese and Western Medicine in Treating Pregnant Women with Intrahepatic Cholestasis].

A clinical observation of therapeutic effect of combined heparin for intrahepatic cholestasis of pregnancy

Comparative Evidence for Intrahepatic Cholestasis of Pregnancy Treatment with Traditional Chinese Medicine Therapy: A Network Meta-Analysis

Treatment Of Intrahepatic Cholestasis Of Pregnancy Using Ursodeoxycholic Acid: A Meta-Analysis

Clinical Analysis of 240 Cases of Intrahepatic Cholestasis of Pregnancy

The Opportunity and the Manner of Delivery in Female with Intrahepatic Cholestasis of Pregnancy

Risk-stratified management strategies for intrahepatic cholestasis of pregnancy: A tertiary center population review over nearly 5 years

Evaluation of neopterin,soluble interleukin-2 receptor and T-helper cell in intrahepatic cholestasis of pregnancy

Diagnostic and prognostic value of blood inflammation and biochemical indicators for intrahepatic cholestasis of pregnancy in Chinese pregnant women

[Clinical analysis of fetal death cases in intrahepatic cholestasis of pregnancy].

Clinical Management Guidelines for Intrahepatic Cholestasis of Pregnancy

Women Successfully Treated for Severe Intrahepatic Cholestasis of Pregnancy Do Not Have Increased Risks for Adverse Perinatal Outcomes

Study on the Mechanisms of Unfavourable Effects of Intrahepatic Cholestasis in Pregnancy on Perinatal Infants

Comparison of perinatal outcome between ICP and chronic hepatitis B with elevated ser-um total bile acid during pregnancy

Effects of intrahepatic cholestasis of pregnancy on hepatic function, changes of inflammatory cytokines and fetal outcomes

A Retrospective Study of the Relation between the Timing and Manner of Delivery and Prognosis in Intrahepatic Cholestasis of Pregnancy

[Meta-Analysis of Ursodeoxycholic Acid and S-adenosylmethionine for Improving the Outcomes of Intrahepatic Cholestasis of Pregnancy].

Associations of clinical subtypes and bile acid levels of intrahepatic cholestasis of pregnancy with pregnancy outcomes

Impaired mixed lymphocyte reaction in intrahepatic cholestasis of pregnancy.